What is Crigler-Najjar syndrome

TL;DR: Crigler-Najjar syndrome is a rare, inherited metabolic disorder characterized by the body’s inability to properly process bilirubin, a yellow pigment produced during the normal breakdown of red blood cells. This condition leads to severe, persistent jaundice from birth and requires lifelong medical management to prevent the accumulation of toxic levels of bilirubin in the brain.

What exactly is Crigler-Najjar syndrome?

Crigler-Najjar syndrome is a rare genetic liver disorder that prevents the body from breaking down bilirubin, a byproduct of red blood cell recycling. In a healthy individual, the liver uses an enzyme called UGT1A1 to convert bilirubin into a water-soluble form that can be safely excreted through bile. In those with Crigler-Najjar syndrome, this enzyme is either entirely missing or functions at a significantly reduced capacity. Because the liver cannot effectively process this pigment, it builds up in the bloodstream, leading to intense yellowing of the skin and whites of the eyes (jaundice). If left untreated, the high levels of unconjugated bilirubin can cross the blood-brain barrier, potentially causing a dangerous neurological condition known as kernicterus.

How are the different types of Crigler-Najjar syndrome classified?

Clinicians typically categorize Crigler-Najjar syndrome into two distinct types based on the severity of the enzyme deficiency and the response to treatment:

• Type I: This is the more severe form. Individuals have a complete absence of the UGT1A1 enzyme activity. Jaundice is severe from birth, and patients are at a high risk for kernicterus, requiring intensive daily phototherapy or a liver transplant to survive.


• Type II (Arias syndrome): This form is milder. Patients retain a small amount of enzyme activity (usually less than 10%). While jaundice is still present, the risk of neurological damage is significantly lower, and the condition often shows a positive response to phenobarbital treatment, which helps induce the remaining enzyme activity.

How common is Crigler-Najjar syndrome and who does it affect?

Crigler-Najjar syndrome is an extremely rare condition, with an estimated prevalence of approximately 1 in 1,000,000 live births worldwide. Because it is an autosomal recessive disorder, both parents must carry a copy of the mutated gene for a child to be affected. It affects males and females equally, and there is no specific geographic predilection, though it is found in populations globally. Symptoms are almost always apparent at birth or within the first few days of life, distinguishing it from other liver conditions that may present later in childhood or adulthood.

What differentiates Crigler-Najjar syndrome from other jaundice conditions?

It is common to confuse Crigler-Najjar syndrome with other causes of jaundice, such as Gilbert’s syndrome. However, the key differentiator is the intensity of the bilirubin levels and the nature of the enzyme deficiency. While Gilbert’s syndrome is common and generally benign, Crigler-Najjar syndrome involves much higher levels of unconjugated bilirubin that do not fluctuate in the same way. Unlike obstructive jaundice, where bile ducts are blocked, the underlying mechanism here is strictly a failure of the liver’s metabolic processing system.

Next steps

• Consult a pediatric hepatologist or metabolic specialist for specialized diagnostic testing, including genetic sequencing of the UGT1A1 gene.


• Join the DiseaseMaps.org community to connect with the 35+ members who have shared their experiences living with this rare condition.


• Speak with a genetic counselor to understand the inheritance pattern and the risks for future family planning.


• Maintain a consistent monitoring schedule for bilirubin levels to mitigate the risk of neurological complications.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Crigler-Najjar syndrome overview.


• Orphanet: Rare disease database entry for Crigler-Najjar syndrome (ORPHA:207).


• OMIM (Online Mendelian Inheritance in Man): UGT1A1 enzyme deficiency records (#218800).


• CureCN: International research consortium focused on gene therapy for Crigler-Najjar syndrome.